Why “American Patients First” is likely to raise drug prices outside of the United States

Why “American Patients First” is likely to raise drug prices outside of the United States

Background: The Trump administration’s ‘American Patients First’ blueprint proposes to reduce drug prices in the USA by increasing drug prices abroad, ex USA. The possibility of the Trump administration to raise drug prices ex USA through legal action via the WTO and bilateral negotiations with fore...

Full description

Bibliographic Details
Main Authors: Monique Dabbous, Cyprien Milea, Steven Simoens, Clement François, Claude Dussart, Lylia Chachoua, Borislav Borissov, Mondher Toumi
Format: Article
Language:English
Published: Taylor & Francis Group 2019-01-01
Series:Journal of Market Access & Health Policy
Subjects:
drug prices
united states of america (usa)
trump
american patients first (apf)
free-loading
bilateralism
multilateralism
world trade organization (wto)
foreign policy
Online Access:http://dx.doi.org/10.1080/20016689.2019.1650596

Internet

http://dx.doi.org/10.1080/20016689.2019.1650596

Similar Items